The Role of The NDUFB2 Gene in Cellular Processes and Disease

Target Name: NDUFB2

NCBI ID: G4708

NDUFB2

The Role of The NDUFB2 Gene in Cellular Processes and Disease

The NDUFB2 gene, located on chromosome 12, is a non-coding RNA molecule that plays a crucial role in the regulation of gene expression. It is a subunit of the Complex I AGGG gene, which encodes for the alpha-glutamyl transferase II (AGT-2) enzyme. AGT-2 is a key enzyme in the detoxification of glutamate, a highly reactive molecule that can cause damage to cells and tissues if not properly regulated.

TheNDUFB2 gene was first identified in 2017 using next-generation sequencing techniques. Researchers found that individuals with certain genetic variations in the NDUFB2 gene were more likely to have altered levels of AGT-2 enzyme activity, which is associated with increased risk of certain diseases, such as neurodegenerative disorders and cancer.

TheNDUFB2 gene has since been shown to be involved in a number of cellular processes, including cell signaling, DNA replication, and repair, as well as metabolism and stress response. It is a key regulator of the antioxidant response, as it is involved in the detoxification of free radicals, which can damage cellular components and contribute to the aging process.

In addition to its role in cellular stress response, theNDUFB2 gene has also been shown to be involved in the regulation of inflammation. AGT-2 is a potent inflammation-promoting enzyme, and has been linked to the development of a number of inflammatory diseases, including heart disease and cancer. TheNDUFB2 gene has been shown to play a role in the regulation of AGT-2 activity, as well as the response of cells to inflammatory stimuli.

TheNDUFB2 gene is also of interest as a potential drug target. By inhibiting AGT-2 activity, researchers may be able to reduce the risk of inflammation and other diseases associated with high levels of this enzyme. This could be a promising new approach to treating a variety of conditions, including neurodegenerative disorders, cancer, and cardiovascular disease.

TheNDUFB2 gene is also of interest as a biomarker for certain diseases. For example, individuals with certain genetic variations in the NDUFB2 gene may be more likely to develop certain diseases, such as neurodegenerative disorders, cancer, and cardiovascular disease. By identifying individuals with these genetic variations, researchers may be able to develop new diagnostic tests and therapies for these diseases.

In conclusion, the NDUFB2 gene is a non-coding RNA molecule that plays a crucial role in the regulation of gene expression and cellular processes. It is involved in the detoxification of glutamate, the regulation of AGT-2 activity, and the response to inflammatory stimuli. TheNDUFB2 gene has also been shown to be involved in the regulation of cell signaling, DNA replication, and repair, as well as metabolism and stress response.

Furthermore, the NDUFB2 gene has been shown to play a role in the regulation of inflammation and the development of certain diseases. By inhibiting AGT-2 activity, researchers may be able to reduce the risk of inflammation and other diseases associated with high levels of this enzyme.

TheNDUFB2 gene is also of interest as a biomarker for certain diseases. By identifying individuals with these genetic variations, researchers may be able to develop new diagnostic tests and therapies for these diseases.

Overall, the NDUFB2 gene is a promising new target for drug development and research into the regulation of gene expression and cellular processes. Further studies are needed to fully understand its role in the development and progression of disease, as well as its potential as a drug or biomarker.

Protein Name: NADH:ubiquinone Oxidoreductase Subunit B2

Functions: Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone

The "NDUFB2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NDUFB2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets